Karen Krasney - Net Worth and Insider Trading
Karen Krasney Net Worth
The estimated net worth of Karen Krasney is at least $21,215 dollars as of 2024-12-01. Karen Krasney is the EVP, General Counsel of Capricor Therapeutics Inc and owns about 1,116 shares of Capricor Therapeutics Inc (CAPR) stock worth over $21,215. Details can be seen in Karen Krasney's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen Krasney has not made any transactions after 2016-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen Krasney
Karen Krasney Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen Krasney owns 1 companies in total, including Capricor Therapeutics Inc (CAPR) .
Click here to see the complete history of Karen Krasney’s form 4 insider trades.
Insider Ownership Summary of Karen Krasney
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2020-02-12 | EVP & GENERAL COUNSEL |
Karen Krasney Latest Holdings Summary
Karen Krasney currently owns a total of 1 stock. Karen Krasney owns 1,116 shares of Capricor Therapeutics Inc (CAPR) as of March 16, 2016, with a value of $21,215.
Latest Holdings of Karen Krasney
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2016-03-16 | 1,116 | 19.01 | 21,215 |
Holding Weightings of Karen Krasney
Karen Krasney Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen Krasney has made a total of 0 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 406 shares on March 16, 2016, which cost Karen Krasney around $9,744.
Insider Trading History of Karen Krasney
- 1
Karen Krasney Trading Performance
GuruFocus tracks the stock performance after each of Karen Krasney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen Krasney is 90%. GuruFocus also compares Karen Krasney's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen Krasney within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Karen Krasney's insider trading performs compared to the benchmark.
Performance of Karen Krasney
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.8 | | | | | |
| Relative Return to S&P 500(%) | 24.16 | | | | | |
Karen Krasney Ownership Network
Karen Krasney Owned Company Details
What does Capricor Therapeutics Inc do?
Who are the key executives at Capricor Therapeutics Inc?
Karen Krasney is the EVP & GENERAL COUNSEL of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and CHIEF FINANCIAL OFFICER Anthony Bergmann .
Capricor Therapeutics Inc (CAPR) Insider Trades Summary
Over the past 18 months, Karen Krasney made no insider transaction in Capricor Therapeutics Inc (CAPR). Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net purchase of 2,798,507 shares made by , and a net purchase of 10,000 shares made by Collier Earl M Jr .
In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 2,798,507 shares, with a net purchase of 2,798,507 shares. During the past 18 months, 0 shares of Capricor Therapeutics Inc (CAPR) were sold and 2,821,500 shares were bought by its insiders, resulting in a net purchase of 2,821,500 shares.
Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Capricor Therapeutics Inc Insider Transactions
Karen Krasney Mailing Address
Above is the net worth, insider trading, and ownership report for Karen Krasney. You might contact Karen Krasney via mailing address: C/o Capricor Therapeutics, Inc., 8840 Wilshire Blvd., 2nd Floor, Beverly Hills Ca 90211.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
